Comparing Two Types of Sedation to Gynaecological Patients
NCT ID: NCT01412632
Last Updated: 2014-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
153 participants
INTERVENTIONAL
2011-11-30
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory Depression of Remimazolam vs. Propofol for Monitored Anesthesia Care
NCT07076628
Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery
NCT07251101
Conditions of Diagnostic Panendoscopy of the Upper Airway Under Propofol Remifentanil General Anesthesia
NCT02093143
TCI vs Manually Controlled Infusion of Propofol
NCT04266535
A Comparison Between Propofol and Etomidate in Hysteroscopy on Effect of Postoperative Sedation and Cognitive Function in Elderly Patients
NCT02147678
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
General vs deep sedation
General anesthesia: remifentanil and propofol Deep sedation: remifentanil, propofol and citanest
Remifentanil, propofol and citanest
iv remifentanil iv propofol im citanest
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remifentanil, propofol and citanest
iv remifentanil iv propofol im citanest
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* females
* are having a TCRE, TCRF or TCRP
* speak and understand Danish
* no mental problems
Exclusion Criteria
* don“t speak or understand Danish
* mental problems
* Lung problems
* BMI \>40
* Big fibroma: \>3x3 cm
* abuser
* Allergy towards i Propofol, Remifentanil and/or Citanest
* pregnant
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Regionshospitalet Horsens
OTHER
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Igor Filipovski
Role: PRINCIPAL_INVESTIGATOR
Regionshospital Horsens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Regionshospitalet Horsens
Horsens, Region Midt, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-023843-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.